Adverse Change in Employment Status After Acute Myocardial Infarction: Analysis From the TRANSLATE-ACS Study.
Adverse Change in Employment Status After Acute Myocardial Infarction: Analysis From the TRANSLATE-ACS Study.
复制标题
急性心肌梗塞后就业状况的不利变化:翻译-ACS研究的分析。
DOI:
10.1161/circoutcomes.117.004528
复制
发表时间:
2018-06
期刊:
影响因子:
--
通讯作者:
Wang TY
中科院分区:
文献类型:
--
作者:
Warraich HJ;Kaltenbach LA;Fonarow GC;Peterson ED;Wang TY
Inability to resume employment after acute myocardial infarction (MI) has important implications for patients. We sought to assess the prevalence of and outcomes associated with adverse change in employment after MI in a national US cohort. The TRANSLATE-ACS study assessed employment status at baseline and 1 year among 9,319 MI patients (mean age 60.8 years, standard deviation [SD] 11.3; 27.3% female) enrolled at 233 US hospitals. We defined adverse change in employment as patients working at baseline but working less or not working at 1 year post-MI. In multivariable models, we assessed factors associated with adverse change in employment and its association with patient-reported depression, health status, persistence to evidence-based medications prescribed at discharge and financial hardship affording medications. Half of patients (51%, n=4,730) were employed at the time of MI. By 1 year, 10% (n=492) of these reported an adverse change in employment, with 3% (n=143) working less and 7% (n=349) no longer working (only 27 of 349 reported retirement). Factors significantly associated with adverse change in employment included number of unplanned readmissions, post-discharge bleeding complications, hypertension, and smoking. At 1 year, patients with an adverse change in employment were more likely to report depression (Patient Health Questionnaire-2 score >3: 27.4% vs. 16.7%), lower health status (mean EuroQoL visual analogue scale: 73 [SD 17.8] vs. 78 [SD 14.8]) and moderate-extreme financial hardship with medication costs (41.0% vs. 28.4%) (all p<0.001). There was no difference in persistence to evidence-based medications prescribed at discharge. Patients who experienced an adverse change in employment after MI reported lower quality of life, increased depression and more difficulty affording medications. These results underscore the need for interventions to address this patient-centered outcome and its health impact. ClinicalTrials.gov; Unique Identifier: NCT01088503
影响因子:
3.8
作者:
Kronish, Ian M.;Rieckmann, Nina;Burg, Matthew M.;Alcantara, Carmela;Davidson, Karina W.
通讯作者:
Davidson, Karina W.